Recruiting
Phase 3

mRNA-1345

Sponsor:

Moderna

Code:

NCT07117487

Conditions

Respiratory Syncytial Virus

Eligibility Criteria

Sex: All

Age: 60+

Healthy Volunteers: Accepted

Interventions

mRNA-1345

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by ModernaTX, Inc. on 2025-08-12.